The targeted next-generation sequencing revealed a recurrent deletion in the MCPH1 gene (also known as BRIT1, NM_024596.3: c.904_916del, rs747489687) in 3/189 of the analyzed patients, these carriers being negative for any other known breast cancer associated gene mutations. Here, MCPH1 is linked to breast cancer.